Investigation of serum sex hormone levels in postmenopausal patients with multiple benign breast lesions detected by mammography

被引:0
|
作者
Liszka, G
Számel, I
Pete, I
Petrányi, A
Udvarhelyi, N
Budai, B
机构
[1] Natl Inst Oncol, Mammog Screening Ctr, H-1122 Budapest, Hungary
[2] Natl Inst Oncol, Dept Clin Res, H-1122 Budapest, Hungary
[3] Natl Inst Oncol, Dept Gynaecol, H-1122 Budapest, Hungary
[4] Natl Inst Oncol, Dept Mol Pathol, H-1122 Budapest, Hungary
关键词
D O I
10.1677/erc.0.0050311
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mammographic appearance of the female breast is influenced by physiological changes related to normal ageing (menopause), endocrine dysfunction, or the combined effects of these factors. During the period from 1 October 1995 to 30 November 1996, mammographic screening was performed on 2356 females from a Budapest district and multiple benign breast lesions (MBBL) were diagnosed in 211 (8.94%) subjects. The hormonal background of this lesion was explored by measuring serum sex hormone levels (oestradiol (E2), progesterone, testosterone, prolactin, FSH and LH) on 40 subjects randomly selected from both Group A (women with involutional changes only) and Group B (patients with MBBL). Serum E2 levels were considerably, but not statistically significantly higher in patients with MBBL (102.2+/-40.2 vs 50.8+/-18.7 pmol/l), whereas the elevations of serum progesterone (2.29+/-0.4 vs 0.901+/-0.5 nmol/l, P=0.0325) and LH (64.3+/-9.4 vs 48.9+/-13.9 IU/l, P=0.0194) levels were statistically significant. In patients with MBBL, parallel histological studies revealed persistent lobules with cell atypia. Consequently, MBBL with distinct radiomorphological features may result from endocrine dysfunction associated with the postmenopausal period. In such cases, cell atypia is more commonly diagnosed by histology. Accordingly, MBBL can be considered as a precancerous lesion. The changes in hormone levels observed suggest that endocrine dysfunction is accompanied by a slight impairment of negative feedback regulation, and regular clinical and laboratory screening of the risk population is recommended.
引用
收藏
页码:311 / 314
页数:4
相关论文
共 50 条
  • [1] Serum sex hormone levels in pre- and postmenopausal breast cancer patients
    Ho, C. C. K.
    Rohaizak, M.
    Zulkifli, S. Z.
    Siti-Aishah, M. A.
    Nor-Aini, U.
    Sharifah-Noor-Akmal, S. H.
    SINGAPORE MEDICAL JOURNAL, 2009, 50 (05) : 513 - 518
  • [2] Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women
    Roni T. Falk
    Elisabet Gentzschein
    Frank Z. Stanczyk
    Montserrat Garcia-Closas
    Jonine D. Figueroa
    Olga B. Ioffe
    Jolanta Lissowska
    Louise A. Brinton
    Mark E. Sherman
    Breast Cancer Research and Treatment, 2012, 131 : 287 - 294
  • [3] Serum sex hormone levels are related to breast cancer risk in postmenopausal women
    Dorgan, JF
    Longcope, C
    Stephenson, HE
    Falk, RT
    Miller, R
    Franz, C
    Kahle, L
    Campbell, WS
    Tangrea, JA
    Schatzkin, A
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 : 583 - 585
  • [4] Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women
    Falk, Roni T.
    Gentzschein, Elisabet
    Stanczyk, Frank Z.
    Garcia-Closas, Montserrat
    Figueroa, Jonine D.
    Ioffe, Olga B.
    Lissowska, Jolanta
    Brinton, Louise A.
    Sherman, Mark E.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (01) : 287 - 294
  • [5] Serum sex hormone levels in postmenopausal women with hypertension
    Phillips, GB
    Jing, TY
    Laragh, JH
    JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (08) : 523 - 526
  • [6] Serum sex hormone levels in postmenopausal women with hypertension
    GB Phillips
    T-Y Jing
    JH Laragh
    Journal of Human Hypertension, 1997, 11 : 523 - 526
  • [7] Flow cytometric DNA analyses of benign breast lesions detected by screening mammography
    Stomper, PC
    DeBloom, JR
    Budnick, RM
    Stewart, CC
    CLINICAL CANCER RESEARCH, 1998, 4 (06) : 1543 - 1547
  • [8] Correlation of serum sex hormone levels with the Gail model risk of breast cancer in postmenopausal women
    Liang, H.
    Lo, S. S.
    Ye, F.
    Costantino, J. P.
    Hudson, A.
    Vogel, V. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] SERUM LEVELS OF ENDOSTATIN, AN ANGIOGENESIS INHIBITOR, IN PATIENTS WITH BENIGN AND MALIGNANT LESIONS OF THE BREAST
    Lima, C. S. P.
    Lourenco, G. J.
    Cardoso Filho, C.
    Favarelli, M. H. C.
    Teori, M. T.
    Goncales, N. S. L.
    Gurgel, M. S. C.
    ANNALS OF ONCOLOGY, 2008, 19 : 53 - 53
  • [10] Serum steroid hormone levels, sex hormone binding globulin, and body mass index in the etiology of postmenopausal breast cancer
    Lipworth, L
    Adami, HO
    Trichopoulos, D
    Carlestrom, K
    Mantzoros, C
    EPIDEMIOLOGY, 1996, 7 (01) : 96 - 100